Effects of octopamine on lipolysis, glucose transport and amine oxidation in mammalian fat cells

Comparative Biochemistry and Physiology - C Pharmacology Toxicology and Endocrinology

Volumn 125, Issue 1, 2000, Pages 33-44

  Fontana, Emi ^a   Morin, Nathalie ^a   Prévot, Danielle ^a   Carpéné, Christian ^a  

^a INSERM   (France)

Author keywords

2 adrenoceptor; 3 adrenoceptor; Adipocyte; Lipolysis; Monoamine oxidase; Octopamine; Semicarbazide sensitive amine oxidase; Tyramine

Indexed keywords

1,3,4,5',6,6',7,12B OCTAHYDRO 1',3' DIMETHYL 2H SPIRO[BENZO[B]FURO[2,3 A]QUINOLIZINE 2,4' PYRIMIDINE] 2' ONE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 [2 [(2 HYDROXY 3 PHENOXYPROPYL)AMINO]ETHOXY] N (2 METHOXYETHYL)PHENOXYACETAMIDE; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ADENOSINE DEAMINASE; ADRENALIN; ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING); BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; BUPRANOLOL; CLONIDINE; INSULIN; ISOPRENALINE; NORADRENALIN; OCTOPAMINE; PARGYLINE; PHENELZINE; PROPRANOLOL; RECEPTOR SUBTYPE; SEMICARBAZIDE; TYRAMINE; YOHIMBINE;

ADIPOCYTE; ADRENERGIC SYSTEM; ADULT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; ENZYME BINDING; FEMALE; GLUCOSE TRANSPORT; HIBERNATION; HUMAN; HUMAN CELL; LIPOLYSIS; NONHUMAN; PHODOPUS; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

ADIPOCYTES; ADRENERGIC ALPHA-AGONISTS; ADULT; AMINES; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CRICETINAE; FEMALE; GLUCOSE; HUMANS; LIPOLYSIS; MIDDLE AGED; NOREPINEPHRINE; OCTOPAMINE; OXIDATION-REDUCTION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, ADRENERGIC, BETA-3;

EID: 0034083710     PISSN: 07428413     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0742-8413(99)00086-9     Document Type: Article

References (35)

1. 2A-adrenoceptor. Br. J. Pharmacol. 122:1997;191-198.
2. Atgié C., Le Gouic S., Marti L., Hanoun N., Casteilla L., Pénicaud L., Ambid L., Carpéné C. Lipolytic and antilipolytic responses of the siberian hamster (Phodopus sungorus sungorus) white adipocytes after weight loss induced by short photoperiod exposure. Comp. Biochem. Physiol. 119A:1998;503-510.
3. Becu-Villalobos D., Thyssen S.M., Rey E.B., Lux-Lantos V., Libertun C. Octopamine and phenylephrine inhibit prolactin secretion both in vivo and vitro. Proc. Soc. Exp. Biol. Med. 199:1992;230-235.
4. Bloom J.D., Dutia M.D., Johnson B.D., Wissner A., Burns M.G., Largis E.E., Dolan J.A., Claus T.H. Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino]propyl]-1,3 benzo dioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta3 receptors. A promising antidiabetic and antiobesity agent. J. Med. Chem. 35:1992;3081-3084.
5. Carpéné C., Chalaux E., Lizarbe M., Estrada A., Mora C., Palacin M., Zorzano A., Lafontan M., Testar X. β3-adrenergic receptors are responsible for the adrenergic inhibition of insulin-stimulated glucose transport in rat adipocytes. Biochem. J. 296:1993;99-105.
6. 3-adrenergic component in catecholamine activation of lipolysis in garden dormouse adipocytes. Am. J. Physiol. 266:1994;R896-R904.
7. Carpéné C., Marti L., Hudson A., Lafontan M. Nonadrenergic imidazoline binding sites and amine oxidase activitis in fat cells. Ann. N.Y. Acad. Sci. 763:1995;380-397.
8. 3-adrenergic agonists in white adipose tissue of mammals. Ann. N.Y. Acad. Sci. 839:1998;186-189.
9. 3-adrenoceptors by octopamine: comparative studies in mammalian fat cells. Naunyn Schmiedeberg's Arch. Pharmacol. 359:1999;310-321.
10. 2A-subtype only: pharmacological and genetic evidence. Fund. Clin. Pharmacol. 9:1995;569-575.
11. David J.C. Relationship between phenolamines and catecholamines during rat brain embryogenic development in vivo and in vitro. J. Neurochem. 43:1984;668-674.
12. Evans P.D., Robb S. Octopamine receptor subtypes and their mode of action. Neurochem. Res. 18:1993;869-874.
13. Faintrenie G., Geloën A. Alpha1-adrenergic stimulation of glucose uptake in rat white adipocytes. J. Pharmacol. Exp. Ther. 286:1998;607-610.
14. 3-adrénergiques du tissu adipeux par l'octopamine. C.R. Acad. Sci. 316:1993;519-523.
15. 3-adrenergic receptor mRNA in man. J. Clin. Invest. 91:1993;344-349.
16. Lafontan M., Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J. Lipid Res. 34:1993;1057-1091.
17. Langin D., Portillo M., Saulnier-Blache J.S., Lafontan M. Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species. Eur. J. Pharmacol. 199:1991;291-301.
18. Lee T.L., Hsu C.T., Yen S.T., Lai C.W., Cheng J.T. Activation of beta3-adrenoceptors by exogenous dopamine to lower glucose uptake into rat adipocytes. J. Auton. Nerv. Syst. 74:1998;86-90.
19. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science. 263:1994;966-969.
20. Lyman C.P. Who is who among the hibernators. Lyman C.P., Willis J.S., Malan A., Wang L.C.H. Hibernation and Torpor in Mammals and Birds. 1982;12-36.
21. Marti L., Morin N., Enrique-Tarancon G., Prévot D., Lafontan M., Testar X., Zorzano A., Carpéné C. Tyramine and vanadate synergistically stimulate glucose transport in rat adipocytes by amine oxidase-dependent generation of hydrogen peroxide. J. Pharmacol. Exp. Ther. 285:1998;342-349.
22. Okina A., Abe K., Inuzuka T., Yano T., Okina T., Nakashima T., Nishiura T. The effects of m-octopamine on salivary flow rates and protein secretion by rat submandibular glands. Comp. Biochem. Physiol. 103C:1992;469-476.
23. Osborne R.H. Insect neurotransmission: neurotransmitters and their receptors. Pharmacol. Ther. 69:1996;117-142.
24. Pinthong D., Wright I.K., Hanmer C., Millns P., Mason R., Kendall D.A., Wilson V.G. Agmatine recognizes alpha2-adrenoceptor binding sites but neither activates nor inhibits alpha2-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;10-16.
25. Raimondi L., Pirisino R., Banchelli G., Ignesti G., Conforti L., Romanelli E., Buffoni F. Further studies on semicarbazide-sensitive amine oxidase activities (SSAO) of white adipose tissue. Comp. Biochem. Physiol. 102B:1992;953-960.
26. Robb S., Cheek T.R., Hannan F.L., Hall L.M., Midgley J.M., Evans P.D. Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems. EMBO J. 13:1994;1325-1330.
27. Roeder T., Degen J., Dyczkowski C., Gewecke M Pharmacology and molecular biology of octopamine receptors from different insect species. Prog. Brain Res. 106:1995;249-258.
28. Roeder T. Pharmacology of the octopamine receptor from locust central nervous tissue (OAR3). Br. J. Pharmacol. 210-216:1995;114.
29. Saavedra J.M. β-phenylethylamine, phenylethanolamine, tyramine and octopamine. Trendelenburg U., Weiner N. Catecholamines II. 1989;181-210.
30. Tavernier G., Galitzky J., Valet P., Remaury A., Bouloumié A., Lafontan M., Langin D. Molecular mechanisms underlying regional variations of catecholamine-induced lipolysis in rat adipocytes. Am. J. Physiol. 268:1995;E1135-E1142.
31. 1-adrenoceptors responsible for the contractile response in the rat corpus carvenosum. Neurosci. Lett. 228:1997;159-162.
32. Trendelenburg U. Classification of sympathomimetic amines. Blaschko H., Muscholl E. Catecholamines. Handbook of Experimental Pharmacology, 33. 1972;336-362.
33. Umekawa T., Yoshida T., Sakane N., Kondo M. Effect of CL316,243, a highly specific beta(3)-adrenoceptor agonist, on lipolysis of human and rat adipocytes. Horm. Metab. Res. 28:1996;394-396.
34. 14C]-deoxy-D-glucose into rat adipocytes in vitro. J. Auton. Pharmacol. 18:1998;13-19.
35. Yu, P.H., 1986. Monoamine oxidase. In: Boulton, A.A., Baker, G.B., Yu, P.H., (Ed.) Neuromethods, Neurotransmitter Enzymes 5, 235-272.